Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth

PHASE3CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

June 30, 1997

Conditions
Herpes Simplex
Interventions
DRUG

acyclovir

Trial Locations (27)

13210

State University of New York - Upstate Medical University, Syracuse

32209

University of Florida Health Science Center - Jacksonville, Jacksonville

35233

Children's Hospital of Alabama, Birmingham

35294

University of Alabama Comprehensive Cancer Center, Birmingham

37920

University of Tennessee Medical Center at Knoxville, Knoxville

44109

MetroHealth Medical Center, Cleveland

63110

St. Louis Children's Hospital, St Louis

70112

Tulane University Medical Center, New Orleans

72202

University of Arkansas, Little Rock

72205

University of Arkansas for Medical Sciences, Little Rock

76104

Cook Children's Medical Center - Fort Worth, Fort Worth

77030

Baylor College of Medicine, Houston

90048

Cedars-Sinai Medical Center, Los Angeles

94305

Stanford University, Stanford

92123-4282

Children's Hospital and Health Center, San Diego

04102

Maine Medical Center, Portland

39216-4505

University of Mississippi Medical Center, Jackson

28232-2861

Carolinas Medical Center, Charlotte

45229-3039

Children's Hospital Medical Center - Cincinnati, Cincinnati

43205-2696

Ohio State University Children's Hospital, Columbus

02903

Rhode Island Hospital, Providence

29425-0721

Medical University of South Carolina, Charleston

37232-6305

Vanderbilt University, Nashville

75235-9032

University of Texas Southwestern Medical School, Dallas

78284-7811

University of Texas Health Science Center at San Antonio, San Antonio

T6G 2R7

University of Alberta, Edmonton

R3A 1R9

University of Manitoba-Winnipeg, Winnipeg

All Listed Sponsors
collaborator

University of Alabama at Birmingham

OTHER

lead

National Center for Research Resources (NCRR)

NIH

NCT00006135 - Phase III Randomized Study of Oral Acyclovir in Infants With Herpes Simplex Virus Infection Limited to Skin, Eyes, and Mouth | Biotech Hunter | Biotech Hunter